Testing new treatments for acute respiratory distress syndrome (ARDS)
Part of Lungs & breathing clinical trials.
This trial is testing new treatments for people with ARDS, a serious lung condition. The goal is to find therapies that help patients breathe better and recover faster. If you or a loved one has ARDS, this study may offer access to experimental treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have ARDS as diagnosed by a doctor (using the Berlin definition).
- You must agree to use birth control (not hormonal) or be abstinent from screening through day 28 (if you could become pregnant).
- You must agree not to join any other research trial while in this study (through day 90).
- You cannot have ARDS caused by trauma, large aspiration, or a blood transfusion.
- You cannot have severe chronic lung diseases (like COPD or pulmonary fibrosis) that need long-term oxygen or a breathing machine.
- You cannot be on a breathing machine or ECMO for ARDS for more than 48 hours before joining.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if bevacizumab can help people with ARDS (a serious lung condition) breathe better. It is for patients with mild, moderate, or severe ARDS who are already in the hospital.
This trial tests a drug called vilobelimab for people with moderate or severe ARDS (a serious lung condition). It aims to find if this treatment can help improve breathing and outcomes.
This trial tests a new medicine called paridiprubart to see if it can help people with moderate or severe acute respiratory distress syndrome (ARDS), a serious lung condition. It may be an option if you have low oxygen levels and no known allergy to the drug.
This study tests a different way of using a breathing machine (ventilator) for people with lung injury (ARDS) to see if it helps them recover better. You might be able to join if you are already on a ventilator in the ICU and meet certain health conditions.
This trial tests a new treatment called IC14 for people in the hospital on a breathing machine for ARDS (a severe lung injury). The study aims to see if IC14, which blocks a protein involved in inflammation, can help the lungs heal faster.
This trial observes the symptoms, treatments, and recovery of patients with acute respiratory distress syndrome (ARDS), a serious lung condition. It aims to learn more about how different types of breathing support affect outcomes.
Hear when a new ARDS trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.